Join us in-person in Milan, Italy for the EASD (European Association for the Study of Diabetes) Annual Meeting 2026. Learn more about our involvement in the event below.
Evotec at EASD 2026
Oral Presentation
Immune-Shielded Stem Cell-Derived Islet Replacement Therapy
Presenter: Katrin Ridders, Principal Scientist, iPSC Cell Therapy
Date and Time: Monday, 28 September, 2026, 5:50 PM (within EASD INNODIA Symposium on T1D Therapies)
Poster Presentations
Genetic Engineering and Validation of Immune-Shielding and Kill-Switch for Safe and Durable iPSC-Based T1D Cell Therapy Without Immunosuppression (Poster #412)
Presenter: Elisa Zanfrini, Research Associate, iPSC Cell Therapy
Session: SO 021 Building better islets: engineered to survive and thrive
Date and Time: 30 Sep 2026; 11.45 am CEST; Short Oral Station 04
Scalable, GMP-Compatible Manufacturing of iPSC-Derived, Immune-Shielded Islet-Like Clusters With Long-Term In Vivo Efficacy as T1D Cell Therapy (Poster #459)
Presenter: Katrin Ridders, Principal Scientist, iPSC Cell Therapy
Session: SO 027 Rebooting the pancreas: advances in islet replacement
Date and Time: 30 Sep 2026; 11.45 am CEST; Short Oral Station 05
